Ann: Updated Strategy and Investor Presentation, page-434

Every minute that Dr T has spent answering questions following the release of the new strategy has been time well spent.

Like many shareholders here, I'm a biotech novice who at best has a "macro" understanding of this industry and the science involved.

Without his contribution here, this forum would have degenerated into a cacophonous quagmire of confusion, disinformation, misinformation, and brawling over what the new strategy may or may not entail.

Treating shareholders with dismissive contempt is par for the course in this game, which makes Dr T's approach all the more refreshing and reassuring for the average shareholder whose risking their hard-earned money in pursuit of that dream escape from the rat race.

I'm here for the long haul, and I'll be exercising my options as soon as possible to do my part and help fund this new strategy.